A
543499
vs
B
BSE Sensex 30
Over the past 12 months, ACHYUT has significantly outperformed BSE Sensex 30, delivering a return of +78% compared to the BSE Sensex 30's 7% drop.
Stocks Performance
543499 vs BSE Sensex 30
Performance Gap
543499 vs BSE Sensex 30
Performance By Year
543499 vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Achyut Healthcare Ltd
Glance View
Achyut Healthcare Ltd. engages in the trading of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2022-03-30. The firm operates in the single business segment of manufacturing pharmaceutical formulations in the forms of tablets, capsules, oral liquids, and injectables. The company is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The firm is engaged in the trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium Carbonate Oyster, Cellulose Acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, among many other products. The firm is in the trading business in both domestic as well as international markets in the countries of the United Arab Emirates (UAE), Kenya, and Nigeria.
